Search for: "ASTRAZENECA LP" Results 81 - 100 of 155
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Sep 2011, 12:38 pm by Matthew Huisman
McDermott Will & Emery has added two lawyers to its life sciences practice in Washington, including the top in-house counsel for AstraZeneca Pharmaceuticals LP, the firm announced Monday. [read post]
7 Aug 2011, 8:36 pm by Patent Docs
Hetero Drugs, Ltd., Unit III et al. 3:11-cv-04468; filed August 2, 2011 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
1 Jun 2011, 11:22 am
Ct. 365, 374 (2008); see also AstraZeneca LP v. [read post]
15 Feb 2011, 4:06 am by Andrew Frisch
AstraZeneca LP, 605 F.Supp.2d 669, 678-79 (W.D.Pa.2009) (discussing why the “professional paradigm” places the physician as the relevant decision maker in the health services industry), aff’d on other grounds, 372 Fed. [read post]
26 Jan 2011, 1:31 am by Ben Vernia
In April of last year, we obtained a $520 million settlement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to resolve allegations that marketing of the anti-psychotic drug Seroquel for uses not approved as safe and effective by the FDA caused false claims to be submitted to federal health care programs. [read post]
29 Dec 2010, 12:54 pm by Bexis
We hope all our readers had excellent holidays, didn’t get stranded in the snow (here on the US East Coast), and received lots of desired presents due to what the economic stats we’ve seen are saying has been a better than expected retailing season. [read post]
1 Dec 2010, 12:15 am by Kelly
Navinta LLC (Property, intangible) Pulmicort Respules (Budesonide) – US: Liability for future indirect infringement: AstraZeneca LP v. [read post]
23 Nov 2010, 1:00 am by Jason Rantanen
By Jason Rantanen In an earlier post, I summarized the Federal Circuit's affirmance of a preliminary injunction prohibiting Apotex from marketing its generic version of AstraZeneca's budesonide in AstraZeneca LP v. [read post]
3 Nov 2010, 5:56 am by The Docket Navigator
Astrazeneca Pharmaceuticals LP, et. al., 2-08-cv-04786 (PAED October 20, 2010, Memorandum and/or Opinion) (Yohn, J.) [read post]
3 Oct 2010, 8:57 pm by Patent Docs
Astrazeneca Pharmaceuticals LP... [read post]
24 Sep 2010, 7:00 am by Kara OBrien
Goldfield, Civil Action No. 10-CV-4430-ER (E.D.P.A.): In this case, the SEC alleges that Self, an Executive Director of Business Development at a pharmaceutical company and Goldfield, a former hedge fund manager, engaged in unlawful insider trading in advance of the April 23, 2007 announcement that AstraZeneca would acquire MedImmune, Inc. [read post]